Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan. - Wikidata - awgldk - TriplyDB

Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.

Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.

http://www.wikidata.org/entity/Q35065349

about

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment Infection with and Carriage of Mycoplasma pneumoniae in Children Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region.Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.Th1/Th2 Cytokine Profile and Its Diagnostic Value in Mycoplasma pneumoniae Pneumonia.Mycoplasma pneumoniae from the Respiratory Tract and Beyond.In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.Mycoplasma pneumoniae: A Potentially Severe Infection.

P2860

Q26742180-20375569-2EA9-47AC-8EBE-D3E2B88314D2 Q26752332-72AB4AF9-C1F5-4688-8480-BD4CD76585A1 Q26767483-0298E4B6-AC5B-49BE-8DB5-73310B99346B Q30367153-24D3C41D-E098-4914-8D16-F0E15A1E35FA Q33801193-137598C6-57B5-4E22-83C6-DD80FE3D9ACB Q34023899-C8CF4728-AC35-468A-9F1D-A106BB86E441 Q36306172-9E601B0F-3D03-491E-9F79-7905C2645CC5 Q36521642-26C70E99-9C24-4D5D-830F-BC184D17B0DB Q39327219-8B82F3C3-AD85-4F4B-9920-AF17C6F49A04 Q40377312-C6CB507A-430F-4284-AF0D-2E803D352E0C Q41987270-4C39673C-E3AB-45EF-B494-E77CA0BE48BF Q50047524-89277D18-0DBE-42A1-B6B7-5408C98F1982 Q55314495-D57F619F-67AD-4826-B64E-2E57616D14EE

P2860

Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.

http://www.wikidata.org/entity/Q35065349

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@ast

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@en

type

label

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@ast

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@en

prefLabel

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@ast

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@en

P1433

Q35065349-F527965C-540F-43B0-93CA-89B4C6FBF9B3

P1476

Q35065349-3B8F0397-FA49-48AB-A524-162FD1EF503F

P2093

Q35065349-11D73D5D-7B30-431B-A17D-372DFA076C11

Q35065349-4C967CF3-6EEE-495D-9EEA-C660792E4814

Q35065349-5E0FCCF7-4887-4B25-B055-2A94EF649328

Q35065349-7A373233-6666-4551-820B-4FF42CA9346F

Q35065349-A5AB52CA-7D78-445C-8658-7D4D293FD427

Q35065349-BD63E3EA-DF48-4269-BA3A-EA9EBB2A7769

Q35065349-CCFDD775-7C71-48FC-83AB-41F6953D4B31

Q35065349-D823EF0E-E4FC-43B0-9F05-29E052E64B06

Q35065349-D9E7B8BB-1F04-4AA0-A217-BFC383BAE1AC

Q35065349-E18C58A0-3560-49E2-989A-51E2D5916DA8

P2860

Q35065349-15C46B9A-25EB-4DD3-B7BC-2131D769621B

Q35065349-26109C56-04CC-44DA-A751-BA59BC2FB4A3

Q35065349-2831370F-9344-4E72-B850-1040FE319247

Q35065349-3727D8A7-0C89-4999-94E7-1A20253FCCCF

Q35065349-4146B86D-D428-4C0D-B43B-9D3C0F7DDCBC

Q35065349-4654E57C-EDC0-481D-8D37-06550AE1FD01

Q35065349-49B7D6C8-A9C5-476A-88B1-EA1DBF9BAA72

Q35065349-58AF2659-E763-4F44-B293-865C305C83A2

Q35065349-7132D243-4A51-413B-A9FA-8009C96D86B2

Q35065349-80CD750F-E08F-4184-919A-AA8B45048AFE

P2888

Q35065349-C7243565-DE9C-466C-98F7-DAE799678F60

P304

Q35065349-192D21B9-C1CC-48B0-B74B-D12C3C1209BD

P31

Q35065349-BD9AF578-622B-4744-9FCC-273290A28581

P356

Q35065349-7B384364-F2FF-4CA3-9F1B-0CB7E5C25056

P478

Q35065349-FB821069-085B-4509-96E0-219E052006B8

P577

Q35065349-BAB61AF2-E561-4769-9572-7014087706E4

P5875

Q35065349-88DA9F88-3D1E-4A86-B3E7-F595FE88D009

P6179

Q35065349-7AF11718-834B-4F90-AC1E-2B4EDEE582F0

P698

Q35065349-AFA9CEEF-AD2A-4344-93E5-2A032BBBE267

P932

Q35065349-FE86BA69-FF75-415C-87FD-0128752555E7

P356

1471-2334-13-591

P1433

BMC Infectious Diseases

P1476

Gene and cytokine profile anal ...... e infection in Fukuoka, Japan.

@en

P2093

Atsushi Fukuoh

http://www.w3.org/2001/XMLSchema#string

Eriko Maeda

http://www.w3.org/2001/XMLSchema#string

Hideaki Yoshitomi

http://www.w3.org/2001/XMLSchema#string

Hitomi Ohya

http://www.w3.org/2001/XMLSchema#string

Kenji Matsumoto

http://www.w3.org/2001/XMLSchema#string

Kentaro Matsuda

http://www.w3.org/2001/XMLSchema#string

Mitsuo Narita

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Sera

http://www.w3.org/2001/XMLSchema#string

Tatsuyuki Kakuma

http://www.w3.org/2001/XMLSchema#string

Yuko Araki

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.

Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011

Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.

Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae.

First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.

P2888

1471-2334-13-591

P304

591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-13-591

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259315962

http://www.w3.org/2001/XMLSchema#string

P6179

1027948332

http://www.w3.org/2001/XMLSchema#string

P698

24330612

http://www.w3.org/2001/XMLSchema#string

P932

3883477

http://www.w3.org/2001/XMLSchema#string